Want to join the conversation?
$AMGN's total revenues for 1Q16 increased by 10% from last year, with 7% product sales growth driven by rheumatoid arthritis treating drug Enbrel, osteoporosis drugs Prolia and XGEVA, as well as long-acting dialysis drug Aranesp, Neulasta (pegfilgrastim), and multiple myeloma drug Kyprolis.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.